US4443547AExpiredUtility

Animal vaccine against colibacillosis, preparation and use

46
Assignee: AGRONOMIQUE INST NAT RECHPriority: Oct 3, 1979Filed: May 6, 1982Granted: Apr 17, 1984
Est. expiryOct 3, 1999(expired)· nominal 20-yr term from priority
C12R 2001/19C12N 1/205A61K 39/0258A61K 2039/552Y10S435/849A61K 2039/545Y02A50/30Y10S424/823
46
PatentIndex Score
4
Cited by
10
References
3
Claims

Abstract

It contains antigens coming from original strains of E.coli (Y + ,31A + and 47A + ) and the known K99 antigen. Application to the vaccination of cows before giving birth for the protection of newborn calves against diarrhea.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A biologically pure culture of a strain of E. coli having the F(31A) surface antigen recognizable by seroagglutination with a specific antiserum of said antigen, prepared from the standard strain (collection n°I-105 at the Institute Pasteur), said antiserum not recognizing the K99 antigen (reference strain B41), or the Y antigen (collection n°I-104), or the 47A antigen (collection n°I-106), said culture when inactivated yielding a vaccine effective in treating diarrhea in newborn animals. 
     
     
       2. A biologically pure culture of a strain of E. coli having the F(Y) surface antigen recognizable by seroagglutination with a specific antiserum of said antigen, prepared from the standard strain (collection n°I-104) said antiserum not recognizing the K99 antigen (reference strain B41) or the 31A antigen (collection n°I-105) or the 47A antigen (collection n°I-106), said culture when inactivated yielding a vaccine effective in treating diarrhea in newborn animals. 
     
     
       3. A biologically pure culture of a strain of E. coli having the F(47A) surface antigen recognizable by seroagglutination with a specific antiserum of said antigen, prepared from the standard strain (collection n°I-106), said antiserum not recognizing the K99 antigen (reference strain B41), or the 31A antigen (collection n°I-105) or the Y antigen (collection n°I-104), said culture when inactivated yielding a vaccine effective in treating diarrhea in newborn animals.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.